2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
about
Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial.Atrial fibrillation: review of current treatment strategiesAtrial fibrillation in women: treatmentEffect of ablation pattern on mechanical function in the atrium.Stand-alone mapping using different transluminal mapping catheters--an accurate and safe way to isolate all pulmonary veins with the cryoballoon?Clinical mapping approach to diagnose electrical rotors and focal impulse sources for human atrial fibrillationAcute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation.Contact force mapping during catheter ablation for atrial fibrillation: procedural data and one-year follow-upLong-term mobility of the esophagus in patients undergoing catheter ablation of atrial fibrillation: data from computer tomography and 3D rotational angiography of the left atrium.Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.Feasibility study of electrocardiographic and respiratory gated, gadolinium enhanced magnetic resonance angiography of pulmonary veins and the impact of heart rate and rhythm on study quality.Management of non-vitamin K antagonist oral anticoagulants in the perioperative settingPersonalized medicine and atrial fibrillation: will it ever happen?How often should we monitor for reliable detection of atrial fibrillation recurrence? Efficiency considerations and implications for study design.Is cryoballoon ablation preferable to radiofrequency ablation for treatment of atrial fibrillation by pulmonary vein isolation? A meta-analysisMeasurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.Adenosine testing after second-generation balloon devices (cryothermal and laser) mediated pulmonary vein ablation for atrial fibrillation.Global left atrial strain in the prediction of sinus rhythm maintenance after catheter ablation for atrial fibrillation.Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study.Robotic ablation of atrial fibrillation.Remote Magnetic versus Manual Navigation for Radiofrequency Ablation of Paroxysmal Atrial Fibrillation: Long-Term, Controlled Data in a Large CohortRecent Atrial Fibrillation Guidelines - Looking at Both Sides of the Atlantic.Estimated pulmonary capillary wedge pressure assessed by speckle tracking echocardiography predicts successful ablation in paroxysmal atrial fibrillation.Mechanisms of arrhythmias and conduction disorders in older adults.Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokesRandomized trial of conventional transseptal needle versus radiofrequency energy needle puncture for left atrial access (the TRAVERSE-LA study).Chronic Kidney Disease and Atrial Fibrillation: A Contemporary Overview.Novel Computational Analysis of Left Atrial Anatomy Improves Prediction of Atrial Fibrillation Recurrence after Ablation.Management of Patients with Atrial Fibrillation: Focus on Treatment Options.Catadioptric Stereo Tracking for Three Dimensional Shape Measurement of MRI Guided Catheters.Anesthesia for electrophysiology studies and catheter ablations.The incidence, diagnosis, and management of pulmonary vein stenosis as a complication of atrial fibrillation ablation.Mapping and ablating stable sources for atrial fibrillation: summary of the literature on Focal Impulse and Rotor Modulation (FIRM).3D X-ray imaging methods in support catheter ablations of cardiac arrhythmias.The Impact of Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation on Healthcare Utilization and Costs: An Economic Analysis From the FIRE AND ICE Trial.Targeting Stable Rotors to Treat Atrial Fibrillation.Catheter Ablation of Long Standing Persistent Atrial Fibrillation: Lessons Learned.Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban.Concomitant unipolar radiofrequency ablation of nonparoxysmal atrial fibrillation in rheumatic and degenerative valve disease.Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation.
P2860
Q24619485-5123760F-208C-46FF-8613-A362B4E5F437Q28073181-D2C55808-25D0-40B6-9E46-60FFB0AE2C65Q30241862-698D8EDC-5019-4AB8-BA1B-855D78C6C779Q30252740-13C37180-B673-48B8-9A3D-02DDB8B46492Q30316895-3F82A3AA-D8C1-4E60-81C0-7CB92629A8F7Q30524182-FAFFB311-8850-456B-8FDB-3F4504E8DC22Q30530209-C1FB12A2-2EAF-43CD-85D5-3066047AA920Q30829413-1C176C87-0A55-42F6-B2A5-5F48A0D63BF3Q31057582-A87FF23F-8E47-4E92-BECE-E552FF22CF18Q32177661-F665DEEA-865B-4704-AEA8-1E6DF06B7DCCQ33831827-05F693EC-7B4E-4226-81A2-26EA7572AD96Q34207558-509C10D0-A087-481E-80AD-B0A18A2A0FEAQ34501117-1D1310FE-3EDD-4830-9714-528CC8B347DBQ35101086-7504EE98-3FCE-4EE0-9CD7-7E07384DA0B9Q35108956-FC977C04-EA9E-44AC-B276-01161B92B322Q35154142-7A6C0467-3F2B-4BE0-81B1-4B3423320DF2Q35205067-19D10A0C-ABD2-49EA-8406-10CA1067344DQ35587890-8B808AF3-2E56-412B-BE82-4C2E40608C2BQ35612069-B76F6253-4079-4B90-9F3C-167299B7DB4FQ35975821-FABF5D7C-290F-4DD9-A051-4FAB837DF157Q36339230-56FCE484-EFF1-40F4-B170-85C49F665B7BQ36461724-3227809C-6EA4-4015-B452-DACBA1AAC43FQ36508785-E6C14A1F-5C06-432E-9644-574194E483CAQ36723709-A7A595AE-4844-4326-BC8F-089D4774AE94Q37301072-1818D63D-480C-4E0C-B2E3-2B0B6693E6D6Q37328844-AD843F35-C6A9-4DBB-8A54-4C12990DAB95Q37495851-46EA6A85-04AA-47B0-B736-0498BF293BE3Q37639472-D036E9C5-BDE2-4573-9F41-F3C90EE2AAAAQ37723881-18740ED6-AF37-4E15-8483-C580E835DB1FQ37739900-A1DA4BB9-3DCC-4E67-A742-3ED13FDACC36Q38069565-C1BC2428-B107-4B9E-AC6F-EAC464FDAE24Q38195774-AF064CEA-ABA5-4ABF-BC13-5A294CCBB309Q38197521-594F3312-C975-4B0A-A683-9E526413CF42Q38223215-7AEC0FEF-3007-41E2-8F7A-C72BB8557668Q38373211-FD41DACD-3F55-4916-B34E-B62119D33419Q38719214-D39AE9BF-B9C1-4016-8768-A2950ED0F549Q38790587-59BE33BA-D1EE-45B2-BA80-26443A943E6EQ38862274-D476C31D-4459-488A-BA89-9659A2B47D72Q39111077-C70DE51C-7E5B-4C3C-8F45-8CCDE7B3C51EQ39234770-2EFFD30E-B4D3-41E2-8B88-C4466D02F5A7
P2860
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
2012 HRS/EHRA/ECAS expert cons ...... nts, and research trial design
@en
2012 HRS/EHRA/ECAS expert cons ...... nts, and research trial design
@nl
type
label
2012 HRS/EHRA/ECAS expert cons ...... nts, and research trial design
@en
2012 HRS/EHRA/ECAS expert cons ...... nts, and research trial design
@nl
prefLabel
2012 HRS/EHRA/ECAS expert cons ...... nts, and research trial design
@en
2012 HRS/EHRA/ECAS expert cons ...... nts, and research trial design
@nl
P2093
P2860
P50
P921
P1476
2012 HRS/EHRA/ECAS expert cons ...... nts, and research trial design
@en
P2093
A John Camm
Andrea Natale
Antonio Raviele
Bruce D Lindsay
D Wyn Davies
David E Haines
David Keane
David Wilber
Douglas L Packer
Eric Prystowsky
P2860
P2888
P304
P356
10.1007/S10840-012-9672-7
P50
P577
2012-03-01T00:00:00Z